Topical Finasteride: A Potential Therapeutic Option for Hidradenitis Suppurativa

    September 2022 in “ Dermatologic Therapy ”
    Marco Manfredini, Antonio Alma, Linda Pongetti … Giovanni Pellacani
    Studysummary This study found that the U.S. stock market responded heterogeneously to the latest presidential elections, with positive reactions in the Energy, Financials, and Industrials sectors but poorer performance among firms with better environmental scores.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on iris.unimore.it →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data American Journal of Clinical Dermatology · 2019
    2. North American Clinical Management Guidelines for Hidradenitis Suppurativa: A Publication from the United States and Canadian Hidradenitis Suppurativa Foundations Journal of the American Academy of Dermatology · 2019

    Related research 6

    1. Topical Finasteride: A Potential Therapeutic Option for Hidradenitis Suppurativa Dermatologic Therapy · 2022
    2. Finasteride in Hidradenitis Suppurativa: A Male Therapy for a Predominantly Female Disease PubMed · 2016
    3. A Case of Hidradenitis Suppurativa Treated Effectively by Finasteride Journal of The American Academy of Dermatology · 2016
    4. Facial Hidradenitis Suppurativa in a 28-Year-Old Male Responding to Finasteride Dermatology · 2012
    5. Hidradenitis Suppurativa Treated With Finasteride Journal of Dermatological Treatment · 2005
    6. Finasteride as a Therapy for Hidradenitis Suppurativa British Journal of Dermatology · 1999